LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

PRIMED Launches 2nd Open Call

04/03/2025

PRESS RELEASE

Brussels, 4 March 2025 - End-Users invited to Test Bio-Based Innovations with Financial Support.

The PRIMED project is inviting companies and innovators to test and refine new bio-based materials, processes, and technologies in real environments. Through its 2nd Open Call, running from March 3 to May 30, 2025, participants can apply for up to €50,000 in funding to refine their innovations and prepare them for market entry, in a collaborative community involving various stakeholders across the value chain.

This call follows the success of PRIMED’s 1st Open Call, which received 17 proposals from companies aiming to integrate bio-based solutions into their operations. Four end-users were selected to work with Living Labs in Portugal, Italy, Ireland, and Finland, developing innovations such as biochar, soil additives, food ingredients and biotissues.

For this 2nd Open Call, PRIMED will select six additional end-users to join the initiative. One Living Lab in Spain will accept at least two end-users, while the remaining four mentioned above will each welcome at least one end-user. The program is looking for companies and organizations working on small-scale projects at Technological Readiness Levels (TRL) from TRL 4-5 to 6-7. These levels correspond to having a functional prototype, ready for practical validation. Proposals should focus on new bio-based materials or ingredients that enhance performance, circular technologies that make better use of biomass, and sustainable solutions that address significant challenges in the industry.

Successful applicants will gain access to PRIMED’s Living Labs, where they will receive support to test and validate their solutions. Apart from funding, the program provides:

  • Laboratory analysis and prototype testing
  • Engineering and technical support
  • Regulatory and market assessments
  • IP strategy and Freedom to Operate
  • Financial and investment planning

Along with this core support, PRIMED offers free expert guidance in fields such as techno-economic evaluations, environmental impact assessments, feasibility studies, and developing business models. These services help guarantee that innovations are scalable, ready for investment, and in line with market needs.

This 2nd Open Call reinforces PRIMED’s mission to integrate waste streams from the primary sector into new value chains and strengthen circular bioeconomy models. Achieving this relies on strong collaboration across sectors, the most effective way to build lasting systems that keep primary sector actors at the core.

 

For more information on eligibility criteria and application guidelines, visit PRIMED’s website.

Contact information : info@primed-project.eu

Authors: Lucía Salinas

PRIMED Launches 2nd Open Call


Download
Share
Communications Team
Communications Team

Related posts

30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.